# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T16:09:44.013396
**Route:** OpenRouter + LaTeX
**Paper Hash:** 69e9f55d5986d1a7
**Tokens:** 16018 in / 2497 out
**Response SHA256:** ab28e1450590ee68

---

No fatal errors found in the four categories you specified. Below is what I checked.

## 1) Data–Design Alignment (Critical)

- **Treatment timing vs. data coverage**
  - **Panel A (1999–2017)**: You explicitly restrict main identification to the **10 states treated 2010–2017**, which is compatible with the panel’s end year 2017. You also correctly note that the **2019–2023 adopters have zero post-treatment observations in Panel A**.
  - **Panel B (2019–2024)**: Covers adoption years up to 2023 (and you explicitly exclude the mid-year 2024 adopters LA/SC from being treated). No “treatment occurs after data end” issue.
  - **Panel C (2000–2023)**: Covers adoption years through 2023. No coverage mismatch.

- **Post-treatment observations**
  - **Panel A**: The 2010–2017 cohorts do have post-treatment years (e.g., 2017 cohort has at least 2017 as post if coded as treated in 2017). That is feasible.
  - **Panel B**: Later cohorts (2021–2023) have both pre- and post- within 2019–2024, so DiD is feasible.
  - No RDD-type cutoff design claimed.

- **Treatment definition consistency**
  - Treatment is consistently described as “in effect” for state-years at/after adoption year.
  - Timing table in Appendix (Table `tab:timing`) matches the adoption-year narrative and the “25 states (2010–2023)” claim.

## 2) Regression Sanity (Critical)

I scanned all reported regression tables (`tab:main_panela`, `tab:main_panelb`, `tab:placebo`, `tab:robustness`) for mechanical impossibilities and “broken output” signals:

- **Standard errors**: None are extreme (no SEs in the thousands; none remotely > 100× the coefficient magnitude in a way that suggests a degenerate regression).
- **Coefficients**: All magnitudes are plausible for outcomes in deaths per 100,000 (no absurd values like >100).
- **Impossible values**: No negative SEs; no R² outside [0,1]; no NaN/Inf shown.
- One item to watch (not fatal under your criteria): reporting “Within R² = N/A” for CS-DiD in Table `tab:main_panela` is fine because you explicitly note it is not defined for that estimator.

## 3) Completeness (Critical)

- No “TBD / TODO / XXX / NA” placeholders in numeric cells.
- Regression tables report **coefficients + SEs + observations** (satisfies the “must report N” requirement).
- Figures and tables referenced in-text appear to exist in the LaTeX source (i.e., labels are defined for all items you cite). I did not verify that the external PDF files actually exist on disk, but there are no *LaTeX-internal* missing references evident from the source.

## 4) Internal Consistency (Critical)

- The core numerical claims in the text match the corresponding tables:
  - Panel A TWFE 1.34 (Table `tab:main_panela`, col 1) and Sun-Abraham 0.54 (col 3) match the narrative and abstract ranges.
  - Randomization inference p-value (0.012) is reported consistently (text + Table `tab:robustness`).
- Treatment cohort counts are consistent: 10 early adopters (2010–2017) in Panel A; total 25 adopters (2010–2023) listed in timing table.

ADVISOR VERDICT: PASS